Finanças

Discussões Sinais técnicos Sazonais

Fluxo de Caixa das Atividades de Financiamento de COEGIN PHARMA.

Dados anuais

2016

2017

2018

2019

2020

2021

2022

2023

2024

TTM

‪0,00‬

‪‪10,00 M‬‬

‪‪20,00 M‬‬

‪‪30,00 M‬‬

‪‪40,00 M‬‬

Período

Valor

Variação

Variação %

TTM

‪‪37,87 M‬‬

‪0,00‬

‪0,00‬%

2024

‪‪37,87 M‬‬

+‪‪14,11 M‬‬

+‪59,42‬%

2023

‪‪23,75 M‬‬

+‪‪19,75 M‬‬

+‪493,85‬%

2022

‪‪4,00 M‬‬

‪‪−25,34 M‬‬

‪−86,37‬%

2021

‪‪29,34 M‬‬

+‪‪5,49 M‬‬

+‪23,00‬%

2020

‪‪23,86 M‬‬

+‪‪7,04 M‬‬

+‪41,85‬%

2019

2018

2017

2016

Dados trimestrais

Q2 '16

Q3 '16

Q4 '16

Q1 '17

Q2 '17

Q3 '17

Q1 '19

Q2 '19

Q1 '20

Q2 '20

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−7,00 M‬‬

‪0,00‬

‪‪7,00 M‬‬

‪‪14,00 M‬‬

‪‪21,00 M‬‬

Período

Valor

Variação

Variação %

Q4 '24

‪‪16,49 M‬‬

+‪‪16,50 M‬‬

—

Q3 '24

‪‪−8,00 K‬‬

‪‪−2,53 M‬‬

‪−100,32‬%

Q2 '24

‪‪2,52 M‬‬

‪‪−16,34 M‬‬

‪−86,62‬%

Q1 '24

‪‪18,86 M‬‬

+‪‪14,86 M‬‬

+‪371,53‬%

Q4 '23

‪‪4,00 M‬‬

+‪‪4,01 M‬‬

—

Q3 '23

‪‪−13,00 K‬‬

‪‪−48,00 K‬‬

‪−137,14‬%

Q2 '23

‪‪35,00 K‬‬

‪‪−19,70 M‬‬

‪−99,82‬%

Q1 '23

‪‪19,73 M‬‬

+‪‪15,73 M‬‬

+‪393,30‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q3 '20

Q2 '20

Q1 '20

Q2 '19

Q1 '19

Q3 '17

Q2 '17

Q1 '17

Q4 '16

Q3 '16

Q2 '16